[SYRS] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
04-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -54.62%
YoY- -52.72%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 5,697 5,162 4,827 5,699 3,828 3,188 2,379 78.89%
PBT -26,027 -22,490 -14,228 -30,130 -19,486 -17,196 -17,226 31.63%
Tax 984 969 967 1,417 0 0 0 -
NP -26,027 -22,490 -14,228 -30,130 -19,486 -17,196 -17,226 31.63%
Tax Rate - - - - - - - -
Total Cost 31,724 27,652 19,055 35,829 23,314 20,384 19,605 37.79%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -456.85 -435.68 -294.76 -528.69 -509.04 -539.40 -724.09 -26.41%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -4.14 -3.60 -2.32 -4.91 -4.26 -3.76 -3.92 3.70%
EPS Diluted -4.14 -3.58 -2.32 -4.91 -4.26 -3.76 -3.92 3.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.